Advanced Heart Failure Therapies for Hypertrophic Cardiomyopathy: State-of-the-Art Review and an Updated Analysis From UNOS.

Abstract

Hypertrophic cardiomyopathy (HCM) is most commonly associated with obstructive symptoms and sudden cardiac death; however, predominantly nonobstructive advanced heart failure in HCM, marked by medically refractory disease with severe functional impairment, occurs in 5% to 7% of patients with HCM. The diagnosis relies on the integration of imaging (echocardiography/cardiac magnetic resonance), hemodynamic data, and cardiopulmonary exercise testing to identify the patients who will benefit from advanced heart failure therapies. Most advanced heart failure therapies focus on systolic dysfunction and are not always applicable to this patient population. Left ventricular assist devices may be an option in a highly selected population with left ventricular dilation. Heart transplantation is often the best option for patients with advanced heart failure in HCM with excellent post-transplantation survival.

• Authors: Lusha W Liang, Heidi S Lumish, Lorenzo R Sewanan, Yuichi J Shimada, Mathew S Maurer, Shepard D Weiner, Gabriel Sayer, Nir Uriel, Kevin J Clerkin
• Journal: JACC. Heart failure (JACC Heart Fail) Vol. 11 Issue 11 Pg. 1473-1480 (Nov 2023) ISSN: 2213-1787 [Electronic] United States
• PMID: 37632495 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Topics

• Humans
• Heart Failure (etiology, therapy, diagnosis)
• Heart Transplantation
• Cardiomyopathy, Hypertrophic (therapy, complications)
• Echocardiography
• Exercise Test